Praxis Precision Medicines (PRAX) Operating Leases (2019 - 2025)

Praxis Precision Medicines' Operating Leases history runs 6 years deep, the most recent figure standing at $110000.0 for Q4 2024.

• In Q4 2024, Operating Leases fell 91.96% year-over-year to $110000.0; the TTM figure through Dec 2024 stood at $110000.0 (down 91.96% YoY), while the FY2024 annual figure was $110000.0, down 91.96% from the prior year.
• Operating Leases for Q4 2024 stood at $110000.0, down from $436000.0 in the prior quarter.
• The five-year high for Operating Leases was $4.2 million in Q3 2021, with the low at $110000.0 in Q4 2024.
• The 5-year median for Operating Leases is $1.9 million (2023), against an average of $2.0 million.
• The sharpest annual moves came in 2021 and 2024: Operating Leases soared 2028.79% in 2021, then tumbled 91.96% in 2024.
• Praxis Precision Medicines' Operating Leases stood at $763000.0 in 2020, then soared by 358.85% to $3.5 million in 2021, then fell by 0.03% to $3.5 million in 2022, then sank by 60.89% to $1.4 million in 2023, then sank by 91.96% to $110000.0 in 2024.
• Business Quant data shows PRAX's Operating Leases at $110000.0 in Q4 2024, $436000.0 in Q3 2024, and $755000.0 in Q2 2024.